| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0004 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.0005 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0005 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0007 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.0008 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.0008 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |